Violation Tracker Individual Record
Company:
Johnson & Johnson
Current Parent Company:
Johnson & Johnson
Penalty:
$541,000,000
Year:
2013
Date:
November 4, 2013
Offense Group:
healthcare-related offenses
Primary Offense:
off-label or unapproved promotion of medical products
Secondary Offense:
kickbacks and bribery
Violation Description:
Johnson & Johnson and its subsidiaries agreed to pay $541 million to resolve multistate litigation alleging unlawful marketing practices, including off-label promotion and kickbacks, to promote the sales of their atypical antipsychotic drugs, Risperdal and Invega. The off-label marketing accounted for $524 million; the other $17 million resolved allegations that J&J subsidiary Janssen paid kickbacks to nuring home pharmacy Omnicare. All of this was part of a larger $2.2 billion civil and criminal settlement involving the federal government; see the Violation Tracker entry at https://violationtracker.goodjobsfirst.org/violation-tracker/-johnson-an...
Level of Government:
state
Action Type:
agency action
Agency:
Multistate Attorneys General Case
Civil or Criminal Case:
civil
HQ Country of Parent:
USA
HQ State of Parent:
New Jersey
Ownership Structure of Parent:
publicly traded
Major Industry of Parent:
pharmaceuticals
Specific Industry of Parent:
pharmaceuticals
Source Notes:
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note:
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.
